Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women [PDF]
Lourdes Ibáñez, Francis de Zegher
openalex +1 more source
Insulin-Like Factor 3: A New Circulating Hormone Related to Luteinizing Hormone-Dependent Ovarian Hyperandrogenism in the Polycystic Ovary Syndrome [PDF]
Alessandra Gambineri+5 more
openalex +1 more source
A comparative study of cutaneous manifestations of hyperandrogenism in obese and non-obese Taiwanese women [PDF]
M.-I. Hsu+5 more
openalex +1 more source
Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography–tandem mass spectrometry and analysis by receiver operator characteristic plots [PDF]
Julian H. Barth+3 more
openalex +1 more source
Association between ACEgene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls [PDF]
Jing Sun+8 more
openalex +1 more source
ESPECTRO FENOTÍPICO DEL SÍNDROME DE OVARIO POLIQUÍSTICO
Antecedentes: El síndrome de ovario poliquístico (SOP) es la endocrinopatía más frecuente en la mujer de edad reproductiva, de etiología incierta y presentación clínica heterogénea. Su diagnóstico y defnición es aún controversial.
Rodrigo Carvajal G+2 more
doaj
Assessing gonadal hormone contributions to affective psychopathologies across humans and animal models [PDF]
Dohanich, GP, Grissom, EM, Müller, Sven
core +1 more source
Insulin Resistance Is a Sufficient Basis for Hyperandrogenism in Lipodystrophic Women with Polycystic Ovarian Syndrome [PDF]
Andreea O. Lungu+4 more
openalex +1 more source
Redefining Polycystic Ovary Syndrome: Transformative Diagnostic and Management Changes in the 2023 Guidelines. [PDF]
Hong AR.
europepmc +1 more source